Orion Oyj : Transfer of 137,000 own B-shares on 1 March 2013

         Orion Oyj : Transfer of 137,000 own B-shares on 1 March 2013


In accordance with a decision by the Board of Directors, Orion Corporation has
on 1 March 2013 transferred altogether 137,000 Orion Corporation B-shares held
by the company as a share reward for earning periods 2010-2012 and 2012 to the
persons employed by the Orion Group and belonging to the Share-based Incentive
Plan of the Orion Group. The transfer is based on the authorisation by the
Annual General Meeting of 24 March 2010. The price per share of the
transferred shares is EUR 22.7936, which is the volume weighted average
quotation of the Orion Corporation B-share on 1 March 2013. Accordingly, the
total transaction price of the transferred shares is EUR 3,122,723.20.

After the share transfer, the total number of own B-shares held by Orion
Corporation is 188,991.

Orion Corporation has informed about the Share-based Incentive Plan in a stock
exchange release on 18 February 2010.

Orion Corporation

Timo Lappalainen  Olli Huotari
President and CEO SVP, Corporate Functions


Orion Corporation
Orionintie 1A, FI-02200 Espoo, Finland

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. Pharmaceutical R&D focuses on central nervous
system drugs, oncology and critical care drugs, and Easyhaler® pulmonary

Orion's net sales in 2012 amounted to EUR 980 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Orion Oyj via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.